PELVIC INFLAMMATORY DISEASE- From Diagnosis to Prevention
Jorma Paavonen MD
Dermatologic Clinics Vol.16 No.4 Oct.1998
Reviewed by Peter Fontana, MD
Definition infection of uterus, fallopian tubes and adjacent pelvic structures not associated with surgery or pregnancy
Risk Factors young age, sexual partners, IUD, douching, smoking, GC, chlamydia, BV; OC may be protective against severe disease
Recent Trends chlamydia>GC outpatient>inpatient
Pathogenesis ascending infection from vaginacervixgenital tract (endometritis salpingitis pyosalpinx/TOA); most cases begin soon after menstrual period (hormonal)
Etiology C. trachomatis (~30% of patients with chlamydial cervicitis develop PID), N. gonorrhea (rates are dropping), BV (#1 cause of vag d/c, role in PID underestimated)
Clinical Picture bilateral lower abd. pain, abnormal vag d/c, metorrhagia, postcoital bleeding, abnormal uterine bleeding, dysuria, fever, nausea, vomiting
Silent/atypical/subclinical disease cervicitis w/o other sxs; may still lead to infertility
Severe disease peritonitis, perihepatitis (Fitzhugh-Curtis)
Dx Major criteria (need all): lower abd. pain/tenderness, adnexal tenderness, CMT
Additional criteria (specificity of dx): fever, d/c, +GC/Chlam, CRP or ESR, WBC
Clinical criteria are insensitive and nonspecific; when compared to laparoscopy (gold standard for dx), pelvic examination is ~60-70% sensitive
Definitive diagnosis via laparoscopy, endometrial biopsy, endovaginal U/S, MRI
Treatment antibiotics are very effective for short-term clinical cure but prevention of long-term sequelae is not known; IUDs should be removed; contraceptive counseling
Inpatient treatment
A: Cefotetan 2g IV q12 or Cefoxitin 2g IV q6 + Doxycycline 100 mg IV/PO q12
B: Clindamycin 900 mg IV q8 + Gentamycin loading dose (2 mg/kg) IV/IM then
maintenance (1.5 mg/kg) q8
Outpatient treatment
A: Ceftriaxone 250 IM or Cefoxitin 2g IM (with Probenicid 1g PO) + Doxycycline
100mg PO bid x 14 days
B: Ofloxacin 400mg PO bid x 14 days + Metronidazole 500mg PO bid x 14 days
Hospitalization recommended for: uncertain dx, pelvic abscess, pregnancy, adolescent age, other severe illness (HIV), failed outpatient treatment, poor follow-up
Outcome worldwide increase in PID over the last few decades has led to secondary epidemics in infertility and ectopics
1 episode of PID 7% relative risk of infertility; 2 episodes16.2%; e3 episodes28%
Women with a history of PID have 7-10fold increased risk for tubal pregnancy, are 10 times more likely to be admitted for abd. pain, and hysterectomy rates are 8 times higher
Prevention STD education and screening for cervicitis (especially chlamydia)